Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

To improve the prognosis of limited stage small cell lung cancer (LS-SCLC) the addition of concurrent thoracic radiotherapy to a platinum-containing regimen is important. In the Netherlands, we initiated a multicenter, phase II study, of the combination of four cycles of carboplatin (AUC 5), paclita...

Descripción completa

Detalles Bibliográficos
Autores principales: Baas, P, Belderbos, J S A, Senan, S, Kwa, H B, van Bochove, A, van Tinteren, H, Burgers, J A, van Meerbeeck, J P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361215/
https://www.ncbi.nlm.nih.gov/pubmed/16465191
http://dx.doi.org/10.1038/sj.bjc.6602979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361215/
https://www.ncbi.nlm.nih.gov/pubmed/16465191
http://dx.doi.org/10.1038/sj.bjc.6602979

Ejemplares similares